Location · Los Angeles, CA
Clinical trials in Los Angeles, CA
1045 recruiting studies have a site in the Los Angeles area, and 275 of them accept healthy volunteers. The area includes Santa Monica, Beverly Hills, Pasadena, Long Beach, Torrance, Inglewood and nearby cities.
1,045 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- Recruiting
Trisol System EFS Study
Trisol Medical
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Open-Label Extension Protocol to SNK01-AD01 Study
NKGen Biotech, Inc.
- Location
- Glendale, CA
- Eligibility basics
- Ages 40–85
- RecruitingPhase 2
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
InSilico Medicine Hong Kong Limited
- Location
- Birmingham, AL + 11 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 1/Phase 2
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
GC Biopharma Corp
- Location
- Los Angeles, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Little Rock, AR + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Phoenix, AZ + 34 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingPhase 1/Phase 2
Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
Luxa Biotechnology, LLC
- Location
- Beverly Hills, CA + 2 other US sites
- Eligibility basics
- Ages 55+
- Recruiting
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Talphera, Inc
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 4
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
Royal Biologics
- Location
- Burbank, CA + 7 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
Adva-Tec
- Location
- Phoenix, AZ + 3 other US sites
- Eligibility basics
- Ages 21–80
- Recruiting
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Aria CV, Inc
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Vanda Pharmaceuticals
- Location
- Newport Beach, CA + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
Bausch Health Americas, Inc.
- Location
- Garden Grove, CA + 3 other US sites
- Eligibility basics
- Ages 5–17
- RecruitingPhase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
AB Science
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–81
- RecruitingPhase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
BioRestorative Therapies
- Location
- Santa Monica, CA + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
Acer Therapeutics Inc.
- Location
- Culver City, CA
- Eligibility basics
- Ages 15–64
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Mobile, AL + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 2
Study of ALTO-300 in MDD
Alto Neuroscience
- Location
- Phoenix, AZ + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Glaukos Corporation
- Location
- Dothan, AL + 19 other US sites
- Eligibility basics
- Ages 2+
- Recruiting
MiGo Tracker Remote Monitoring of Home Exercise After Stroke
Flint Rehabilitation Devices, LLC
- Location
- Downey, CA
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
MSC EVs in Dystrophic Epidermolysis Bullosa
Aegle Therapeutics
- Location
- Phoenix, AZ + 2 other US sites
- Eligibility basics
- Ages 6 mo+
- RecruitingPhase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
GIE Medical
- Location
- Scottsdale, AZ + 32 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
GIE Medical
- Location
- Scottsdale, AZ + 30 other US sites
- Eligibility basics
- Ages 22+